Main Subjects = Radionuclide Therapy
Partial volume effect in SPECT & PET image and impact on radionuclide dosimetry estimates

Articles in Press, Corrected Proof, Available Online from 17 May 2022

10.22038/aojnmb.2022.63827.1448

Dale L Bailey; Harry Marquis; Kathy P Willowson


Therapeutic outcomes of 177Lu-PSMA-617 targeted therapy in patients with metastatic castration-resistant prostate cancer: A single-center study

Articles in Press, Accepted Manuscript, Available Online from 27 May 2022

10.22038/aojnmb.2022.64964.1454

Seyed Ali Mirshahvalad; Saeed Farzaneh Far; Mehrshad Abbasi


Feasibility of high-dose iodine-131-metaiodobenzylguanidine therapy for high-risk neuroblastoma preceding myeloablative chemotherapy and hematopoietic stem cell transplantation: a study protocol

Volume 6, Issue 2, July 2018, Pages 161-166

10.22038/aojnmb.2018.29845.1203

Raita Araki; Ryosei Nishimura; Anri Inaki; Hiroshi Wakabayashi; Yasuhito Imai; Yoshikazu Kuribayashi; Kenichi Yoshimura; Toshinori Murayama; Seigo Kinuya


Utility of F-18 FDG PET/CT for Detection of Bone Marrow Metastases in Prostate Cancer Patients Treated with Radium-223

Volume 6, Issue 1, January 2018, Pages 61-67

10.22038/aojnmb.2017.9896

Kaoru Maruyama; Keita Utsunomia; Takahiro Nakamoto; Shigenari Kawakita; Takashi Murota; Noboru Tanigawa


Production, biodistribution assessment and dosimetric evaluation of 177Lu-TTHMP as a bone pain palliation agent

Volume 3, Issue 1, January 2015, Pages 35-42

10.7508/aojnmb.2015.01.006

samaneh zolghadri; hassan yousefnia; amir reza jalilian; mohammad ghannadi-maragheh